As a platform company, the company will provide related services based on high-throughput catalytic screening technology for the domestic and foreign pharmaceutical industries, and the specific contents are as follows: 1) Provide domestic and foreign pharmaceutical customers on the established high-throughput catalytic screening platform The high-throughput catalytic screening service helps customers greatly shorten the R&D cycle and reduce R&D costs. 2) Help customers carry out kilogram scale-up verification and purification process development of catalytic reactions, and provide 100-kilogram production process technology packages. 3) Some traditional production processes are backward, high in pollution, high in cost, and high in risk. Catalytic technology can be used to replace the R&D and sales of high value-added molecular inserts and novel structures of pharmaceutical intermediates. 4) Evaluation, development, production and sales of new catalysts.